hematopoietic system
• reduced Ighg3 and increased Ighg2b surface expression when CD43- splenic B cells were induced to switch
• reduced switching to Ighg3 and increased switching to Ighg2b in LPS-stimulated pro-B cells
• normal Ighg2a and Ighg1 surface expression when CD43- splenic B cells were induced to switch
• reduced Ighg3 and increased Ighg2a and Ighg2b serum levels 28 days after immunization with TNP-Ficoll
|
• increased Ighg2a serum levels 28 days after immunization with TNP-Ficoll
• normal Ighg2a surface expression when CD43- splenic B cells were induced to switch
|
• increased Ighg2b surface expression when CD43- splenic B cells were induced to switch
• increased Ighg2b serum levels 28 days after immunization with TNP-Ficoll
|
• reduced Ighg3 surface expression when CD43- splenic B cells were induced to switch
• reduced Ighg3 serum levels 28 days after immunization with TNP-Ficoll
|
immune system
• reduced Ighg3 and increased Ighg2b surface expression when CD43- splenic B cells were induced to switch
• reduced switching to Ighg3 and increased switching to Ighg2b in LPS-stimulated pro-B cells
• normal Ighg2a and Ighg1 surface expression when CD43- splenic B cells were induced to switch
• reduced Ighg3 and increased Ighg2a and Ighg2b serum levels 28 days after immunization with TNP-Ficoll
|
• increased Ighg2a serum levels 28 days after immunization with TNP-Ficoll
• normal Ighg2a surface expression when CD43- splenic B cells were induced to switch
|
• increased Ighg2b surface expression when CD43- splenic B cells were induced to switch
• increased Ighg2b serum levels 28 days after immunization with TNP-Ficoll
|
• reduced Ighg3 surface expression when CD43- splenic B cells were induced to switch
• reduced Ighg3 serum levels 28 days after immunization with TNP-Ficoll
|